Search Results

91 items found for "Pamela S Becker"

Posts (51)

Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus
Here we report that neuropeptide S (NPS) signaling in the PVT is necessary for stimulus salience encoding
Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company
Dr. Alexander S. Hauser receives the Bachem award for peptide science
November 2021 Read more at the source #DrGPCR #GPCR #IndustryNews

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Megan Othus , Kelsey-Leigh A Garcia , Mary-Elizabeth M Percival , Ryan D Cassaday , Vivian G Oehler , Pamela S Becker , Jacob S Appelbaum , Janis L Abkowitz , Johnnie J Orozco , Siobán B Keel , Paul C Hendrie
Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
Boris Aguilar, Lauren Hagen, Jeannine McCune, Richard Gelinas, Raymond J Monnat Jr, Ilya Shmulevich, Pamela S Becker Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Authors Peter J P Croucher , Maya Ridinger , Pamela S Becker , Tara L Lin , Sandra L Silberman , Eunice S Wang , Amer M Zeidan Tags AML , Biomarker , Hypomethylating agents , Onvansertib , PLK1 , Splicing